يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Rita Agostino"', وقت الاستعلام: 1.45s تنقيح النتائج
  1. 1
    Myositis/myasthenia after pembrolizumab in a bladder cancer patient with an autoimmunity-associated HLA: Immune–biological evaluation and case report

    المؤلفون: Roberto Maisano, Giovanna Orizzonte, Giorgio Restifo, Pierpaolo Correale, Michele Caraglia, Vincenzo Dattola, Cirino Botta, Rita Agostino, Rita Emilena Saladino, Domenico Mazzacuva, Rocco Giannicola, Antonia Consuelo Falzea, Natale Daniele Calandruccio, Antonino Mafodda, Umberto Aguglia, Giovanna Bianco, Eleonora Iuliano, Vittoria Cianci

    المساهمون: Botta, C., Agostino, R. M., Dattola, V., Cianci, V., Calandruccio, N. D., Bianco, G., Mafodda, A., Maisano, R., Iuliano, E., Orizzonte, G., Mazzacuva, D., Falzea, A. C., Saladino, R. E., Giannicola, R., Restifo, G., Aguglia, U., Caraglia, M., Correale, P., Botta C., Agostino R.M., Dattola V., Cianci V., Calandruccio N.D., Bianco G., Mafodda A., Maisano R., Iuliano E., Orizzonte G., Mazzacuva D., Falzea A.C., Saladino R.E., Giannicola R., Restifo G., Aguglia U., Caraglia M., Correale P.

    المصدر: International Journal of Molecular Sciences, Vol 22, Iss 6246, p 6246 (2021)
    International Journal of Molecular Sciences

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Case Report, Autoimmunity, Pembrolizumab, PD1-checkpoint inhibitors, medicine.disease_cause, 0302 clinical medicine, Antineoplastic Agents, Immunological, Biology (General), HLA Antigen, Myositi, PD1-checkpoint inhibitor, Spectroscopy, Myositis, General Medicine, Computer Science Applications, Myasthenia Gravi, Chemistry, Pyridostigmine, urothelial cancer, 030220 oncology & carcinogenesis, Urinary Bladder Neoplasm, Class-I/II HLA, Myasthenia, medicine.drug, Human, medicine.medical_specialty, QH301-705.5, Prognosi, Human leukocyte antigen, Antibodies, Monoclonal, Humanized, Catalysis, Inorganic Chemistry, 03 medical and health sciences, Internal medicine, medicine, Physical and Theoretical Chemistry, Adverse effect, Molecular Biology, QD1-999, Aged, business.industry, Organic Chemistry, Cancer, medicine.disease, Discontinuation, 030104 developmental biology, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5f1730fa5ddbbe610ba6d945569661Test
    http://hdl.handle.net/11591/462420Test


    أضف إلى المفضلة
  2. 2
    Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab

    المؤلفون: Antonia Consuelo Falzea, Valerio Nardone, Rocco Giannicola, Vito Barbieri, Nicoletta Staropoli, Graziella Calabrese, Graziella D'Arrigo, Marika Monoriti, Cirino Botta, Pierfrancesco Tassone, Pierosandro Tagliaferri, Pietro Del Medico, Pierpaolo Correale, Giovanni Tripepi, Pierpaolo Pastina, Teresa Del Giudice, Rita Agostino, Luigi Pirtoli

    المساهمون: Giannicola R., D'arrigo G., Botta C., Agostino R., Del Medico P., Falzea A.C., Barbieri V., Staropoli N., Del Giudice T., Pastina P., Nardone V., Monoriti M., Calabrese G., Tripepi G., Pirtoli L., Tassone P., Tagliaferri P., Correale P., Giannicola, R, D'Arrigo, G, Botta, C, Agostino, R, Del Medico, P, Falzea, Ac, Barbieri, V, Staropoli, N, Del Giudice, T, Pastina, P, Nardone, V, Monoriti, M, Calabrese, G, Tripepi, G, Pirtoli, L, Tassone, P, Tagliaferri, P, Correale, P

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, IrAE, Extractable nuclear antigens, medicine.medical_treatment, Salvage therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Lung cancer, Adverse effect, MNSCLC, Chemotherapy, Auto-antibodie, PD-1/PDL-1-blockade, business.industry, Hazard ratio, Cancer, Articles, medicine.disease, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Nivolumab, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ea65fae89e1e2a8e0f0281ab68e9397Test
    http://hdl.handle.net/10447/512790Test


    أضف إلى المفضلة
  3. 3
    How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies

    المؤلفون: Valerio Nardone, Pierpaolo Pastina, Rocco Giannicola, Rita Agostino, Stefania Croci, Paolo Tini, Luigi Pirtoli, Antonio Giordano, Pierosandro Tagliaferri, Pierpaolo Correale

    المساهمون: Nardone, V, Pastina, P, Giannicola, R, Agostino, R, Croci, S, Tini, P, Pirtoli, L, Giordano, A, Tagliaferri, Pierosandro, Correale, Pierpaolo

    المصدر: Frontiers in Immunology, Vol 9 (2018)
    Frontiers in Immunology

    مصطلحات موضوعية: 0301 basic medicine, Oncology, lcsh:Immunologic diseases. Allergy, Opinion, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Immunology, NSCLC, chemotherapy, radiation therapy, HNSCC, 03 medical and health sciences, 0302 clinical medicine, Text mining, Drug Therapy, immunotherapy, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, Immunology and Allergy, Chemotherapy, Radiotherapy, business.industry, Immunotherapy, Combined Modality Therapy, Radiation therapy, Treatment Outcome, 030104 developmental biology, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Non small lung cancer, business, lcsh:RC581-607

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c265c308177e7a5d85d9a49f54e974b2Test
    https://www.frontiersin.org/article/10.3389/fimmu.2018.02941/fullTest


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث